| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.22709 |
| P698 | PubMed publication ID | 19177576 |
| P2093 | author name string | International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular Neoplasia | |
| P2860 | cites work | Management of hepatocellular carcinoma | Q29616230 |
| Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. | Q30332934 | ||
| Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging | Q33259549 | ||
| Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors | Q33750538 | ||
| Role of the heat shock response and molecular chaperones in oncogenesis and cell death | Q34052682 | ||
| Chaperones in cell cycle regulation and mitogenic signal transduction: a review | Q34095732 | ||
| Heat shock proteins: endogenous modulators of apoptotic cell death | Q34340472 | ||
| A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. | Q34579605 | ||
| Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. | Q34585928 | ||
| Dysplastic nodules and hepatocarcinogenesis | Q34746241 | ||
| Early hepatocellular carcinoma as an entity with a high rate of surgical cure | Q34754443 | ||
| Morphological changes of early human hepatocarcinogenesis | Q35746256 | ||
| Preneoplastic lesions in human hepatocarcinogenesis | Q36033377 | ||
| Liver cell dysplasia: a premalignant condition | Q36647931 | ||
| Overexpression of glutamine synthetase in human primary liver cancer | Q36721680 | ||
| Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. | Q36728718 | ||
| Hepatic precancerous lesions and small hepatocellular carcinoma. | Q36998495 | ||
| Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling | Q38359851 | ||
| Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions | Q38430586 | ||
| Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles | Q39227229 | ||
| Identification of glypican-3 as a novel tumor marker for melanoma | Q40505788 | ||
| Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma | Q41936556 | ||
| Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants | Q44810709 | ||
| The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection | Q45407203 | ||
| Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver | Q47964538 | ||
| Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis | Q49212675 | ||
| Clonal analysis of macronodules in cirrhosis. | Q50864501 | ||
| Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. | Q52025753 | ||
| Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views. | Q52213263 | ||
| Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. | Q53342426 | ||
| Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. | Q53562749 | ||
| Glypican-3 is overexpressed in human hepatocellular carcinoma. | Q53654099 | ||
| Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis | Q57972703 | ||
| Complementary distribution of carbamoylphosphate synthetase (ammonia) and glutamine synthetase in rat liver acinus is regulated at a pretranslational level | Q63359460 | ||
| Morphologic studies of the liver cell dysplasia | Q67292945 | ||
| Localization of ammonia-metabolizing enzymes in human liver: ontogenesis of heterogeneity | Q69367862 | ||
| Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas | Q69380733 | ||
| Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases | Q69514555 | ||
| Functional hepatocyte heterogeneity in ammonia metabolism. The intercellular glutamine cycle | Q69871608 | ||
| Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study | Q72590102 | ||
| Stromal and blood vessel wall invasion in well-differentiated hepatocellular carcinoma | Q73137140 | ||
| Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma | Q73638685 | ||
| Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation | Q73807724 | ||
| Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans | Q74203499 | ||
| Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients | Q74333839 | ||
| Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis | Q74635411 | ||
| Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD | Q75384299 | ||
| Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers | Q79219082 | ||
| Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules | Q79298091 | ||
| Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas | Q80238304 | ||
| Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations | Q80289157 | ||
| The values and limitations of glypican-3 as a novel tumor marker for hepatocellular carcinoma from clinical and economic viewpoints | Q80428386 | ||
| Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma | Q81469151 | ||
| Diagnostic discrepancy of early hepatocellular carcinoma between Japan and West | Q95827819 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 658-664 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia | |
| P478 | volume | 49 |
| Q34640456 | A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values |
| Q57150013 | ACG clinical guideline: the diagnosis and management of focal liver lesions |
| Q91654805 | Ablative therapies for hepatic and biliary tumors: endohepatology coming of age |
| Q53196323 | Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. |
| Q26772334 | Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma |
| Q90114767 | Altered glycosylation associated with dedifferentiation of hepatocellular carcinoma: a lectin microarray-based study |
| Q95276807 | Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging |
| Q43484356 | Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging |
| Q41962614 | Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
| Q53165025 | Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. |
| Q38830332 | Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging |
| Q36995470 | Assessment of hemodynamics in a rat model of liver cirrhosis with precancerous lesions using multislice spiral CT perfusion imaging |
| Q38367782 | Assessment of stromal invasion for correct histological diagnosis of early hepatocellular carcinoma |
| Q49201062 | Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population |
| Q91599654 | Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging |
| Q36100711 | Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma |
| Q38450711 | Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. |
| Q58021004 | Biopsy for liver cancer: how to balance research needs with evidence-based clinical practice |
| Q26766707 | Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma |
| Q52427794 | CRISPR/Cas9-based Pten knock-out and Sleeping Beauty Transposon-mediated Nras knock-in induces hepatocellular carcinoma and hepatic lipid accumulation in mice. |
| Q34681076 | CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects |
| Q26795780 | Cell-block procedure in endoscopic ultrasound-guided-fine-needle-aspiration of gastrointestinal solid neoplastic lesions |
| Q39358916 | Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma |
| Q52996930 | Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US. |
| Q58707841 | Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma |
| Q41092750 | Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma |
| Q57763097 | Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma |
| Q43987263 | Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM. |
| Q82538934 | Chronic Hepatitis and Cirrhosis on MR Imaging |
| Q33642605 | Cirrhotic Rat Liver: Reference to Transporter Activity and Morphologic Changes in Bile Canaliculi—Gadoxetic Acid–enhanced MR Imaging |
| Q38495409 | Cirrhotic liver: What's that nodule? The LI-RADS approach. |
| Q60455282 | Claudins and tricellulin in fibrolamellar hepatocellular carcinoma |
| Q86908198 | Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study |
| Q48366451 | Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular Carcinoma |
| Q37935712 | Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques |
| Q36400259 | Clinical guideline SEOM: hepatocellular carcinoma |
| Q44297744 | Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm. |
| Q43115840 | Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma |
| Q51052720 | Coexpression of organic anion-transporting polypeptides 1B3 and multidrug-resistant proteins 2 increases the enhancement effect of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on hepatocellular carcinoma in magnetic resonance imaging. |
| Q37794906 | Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate‐ and ferucarbotran‐enhanced magnetic resonance imaging |
| Q36187574 | Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis. |
| Q90247962 | Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes |
| Q35148664 | Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging |
| Q54079238 | Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma. |
| Q45161424 | Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. |
| Q37899575 | Contribution of biomarkers and imaging in the management of hepatocellular carcinoma |
| Q56985572 | Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis |
| Q26864205 | Current concepts in the immunohistochemical evaluation of liver tumors |
| Q64959827 | Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practice. |
| Q42704441 | Current limitations and potential breakthroughs for the early diagnosis of hepatocellular carcinoma. |
| Q38030347 | Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review |
| Q38408866 | Diagnosis and treatment of hepatocellular carcinoma: An update |
| Q27027855 | Diagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current Consensus |
| Q44481786 | Diagnosis of and therapy for hepatocellular carcinoma |
| Q53272486 | Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. |
| Q33668652 | Diagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay |
| Q89070708 | Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers |
| Q57972656 | Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma |
| Q89824104 | Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute |
| Q37972809 | Diagnostic imaging of hepatocellular carcinoma: recent progress |
| Q38869595 | Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis |
| Q58097155 | Diagnostik und Früherkennung des hepatozellulären Karzinoms |
| Q43904191 | Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging |
| Q89017577 | Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging |
| Q93054417 | Differentiation of Small Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison Over Gadoxetic Acid-Enhanced MR and Diffusion-Weighted Imaging |
| Q36325824 | Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. |
| Q36454678 | Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature. |
| Q31119452 | Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model |
| Q47913734 | EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice. |
| Q38899783 | Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions? |
| Q42121689 | Early hepatocellular carcinoma |
| Q40584888 | Early hepatocellular carcinoma as a signaling lesion for subsequent malignancy |
| Q36801176 | Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions |
| Q41824372 | Early hepatocellular carcinoma: definition and diagnosis |
| Q86109797 | Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound |
| Q54265295 | Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation. |
| Q30417051 | Elastography and Contrast-enhanced Ultrasonography in the Early Detection of Hepatocellular Carcinoma in an Experimental Model of Nonalcoholic Steatohepatitis |
| Q33802693 | Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients |
| Q38844380 | Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging |
| Q36217858 | Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. |
| Q36968020 | Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27 |
| Q85642880 | Evaluation and comparison of microvessel density using the markers CD34 and CD105 in regenerative nodules, dysplastic nodules and hepatocellular carcinoma |
| Q46379419 | Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. |
| Q51204767 | Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. |
| Q36104399 | Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets |
| Q33648955 | Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma |
| Q38681385 | Fine Needle Aspiration Biopsy (FNAB) in the Diagnosis of Hepatocellular Carcinoma: A Review |
| Q37901565 | Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis |
| Q35101651 | Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations |
| Q27028207 | Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI |
| Q38117581 | Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management |
| Q40071003 | From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world |
| Q47842185 | From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma. |
| Q51507919 | From liver cirrhosis to HCC. |
| Q38614249 | Functional and genetic deconstruction of the cellular origin in liver cancer. |
| Q53525275 | Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria |
| Q45344386 | Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma |
| Q84274443 | Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow |
| Q35759029 | Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma |
| Q31113966 | Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker |
| Q26827487 | Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma |
| Q46704093 | Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients |
| Q28084003 | Guide for diagnosis and treatment of hepatocellular carcinoma |
| Q28278903 | Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS |
| Q37886275 | HCV-related liver cancer in people with haemophilia. |
| Q38645986 | HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2. |
| Q38725577 | Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential |
| Q53085717 | Hemodynamics and progression of a hypervascular focus in a borderline lesion of hepatocellular carcinoma: analysis by angiography-assisted CT and histopathology. |
| Q38155513 | Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. |
| Q64946659 | Hepatic stem cells and cancers: a pathologist's view. |
| Q38238010 | Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma |
| Q41258546 | Hepatobiliary quiz-5 (2013). |
| Q46073789 | Hepatocarcinogenesis and LI-RADS. |
| Q37832405 | Hepatocarcinogenesis: imaging-pathologic correlation. |
| Q37832407 | Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis |
| Q26740616 | Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response |
| Q37350820 | Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran |
| Q64286645 | Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances |
| Q57756376 | Hepatocellular carcinoma |
| Q37031754 | Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields |
| Q87412446 | Hepatocellular carcinoma and nodular regenerative hyperplasia after chemotherapy for metastatic colorectal carcinoma |
| Q37402242 | Hepatocellular carcinoma from an immunologic perspective |
| Q59796728 | Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist |
| Q53058849 | Hepatocellular carcinoma: clinical significance of signal heterogeneity in the hepatobiliary phase of gadoxetic acid-enhanced MR imaging. |
| Q37355835 | Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics |
| Q37832406 | Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR. |
| Q53944144 | Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas. |
| Q42114895 | Hepatocellular tumors: immunohistochemical analyses for classification and prognostication |
| Q37064910 | High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions |
| Q44480005 | High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging in cirrhosis or chronic hepatitis: incidence and predictive factors for hypervascular transformation, preliminary results |
| Q36214807 | Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination |
| Q46105464 | Histological characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on gadoxetic acid-enhanced MR imaging |
| Q83753619 | Histological diagnosis of early hepatocellular carcinoma |
| Q47825087 | Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma. |
| Q57782429 | Histology/pathology |
| Q64262736 | Histopathological characteristics of needle core biopsy and surgical specimens from patients with solitary hepatocellular carcinoma or intrahepatic cholangiocarcinoma |
| Q53467129 | Histopathological classification of hepatocellular carcinoma. |
| Q50238484 | Histopathological diagnosis of early HCC through biopsy: efficacy of Victoria blue and cytokeratin 7 staining |
| Q34552007 | Histopathology of hepatocellular carcinoma |
| Q37087484 | Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors |
| Q36236839 | How do persistent infections with hepatitis C virus cause liver cancer? |
| Q27001669 | How grim is hepatocellular carcinoma? |
| Q36277809 | How normal is the liver in which the inflammatory type hepatocellular adenoma develops? |
| Q39381803 | How to Differentiate Borderline Hepatic Nodules in Hepatocarcinogenesis: Emphasis on Imaging Diagnosis |
| Q89624092 | How to improve HCC surveillance outcomes |
| Q41465593 | Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis. |
| Q48317424 | Human primary liver cancer-derived organoid cultures for disease modeling and drug screening |
| Q37732370 | Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images |
| Q44419410 | Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma |
| Q46593010 | Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI. |
| Q26768463 | Imaging of HCC-Current State of the Art |
| Q55130824 | Imagiological Diagnosis of Gastrointestinal Diseases - Diagnostic Criteria of Hepatocellular Carcinoma. |
| Q56896669 | Immunotherapy of hepatocellular carcinoma |
| Q85120671 | Improved diagnosis of well‐differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid‐enhanced magnetic resonance imaging and Sonazoid contrast‐enhanced ultrasonography |
| Q33728805 | Increased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients. |
| Q51504063 | Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: biopsy for all, some, or none? |
| Q48111678 | Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis |
| Q64986469 | Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI. |
| Q92326490 | Intravital assessment of angioarchitecture in rat hepatocellular nodules using in vivo fluorescent microscopy |
| Q93068932 | Intravoxel Incoherent Motion Diffusion-Weighted Imaging for Evaluation of the Cell Density and Angiogenesis of Cirrhosis-Related Nodules in an Experimental Rat Model: Comparison and Correlation With Dynamic Contrast-Enhanced MRI |
| Q87145592 | Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease? |
| Q40072345 | Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies? |
| Q52916843 | Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study. |
| Q38791960 | Latest developments in precancerous lesions of hepatocellular carcinoma |
| Q35740127 | Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules |
| Q53302727 | Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis. |
| Q42876514 | Liver Cancer Working Group report. |
| Q54288930 | Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. |
| Q35913384 | Liver cancer oncogenomics: opportunities and dilemmas for clinical applications |
| Q37860680 | Liver precancerous lesions and hepatocellular carcinoma: the histology report. |
| Q42244047 | Liver transplantation in a child with multifocal hepatocellular carcinoma hepatitis C and management of post-transplant viral recurrence using boceprevir |
| Q35619951 | MRI features of hepatocellular carcinoma related to biologic behavior |
| Q53123794 | MRI for hepatocellular carcinoma: a primer for magnetic resonance imaging interpretation. |
| Q38408881 | Magnetic resonance imaging of the cirrhotic liver: An update |
| Q28258769 | Management of HCC |
| Q51541140 | Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. |
| Q27860530 | Management of hepatocellular carcinoma: An update |
| Q27005624 | Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound |
| Q60912969 | MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer |
| Q28087569 | Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine |
| Q37812000 | Modern Approach to Hepatocellular Carcinoma |
| Q40055042 | Molecular characteristics of fibrolamellar hepatocellular carcinoma. |
| Q42610253 | Molecular classification and clonal differentiation of hepatocellular carcinoma: the step forward for patient selection for liver transplantation. |
| Q37680387 | Molecular events in hepatic preneoplasia: a review |
| Q26745338 | Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances |
| Q34954493 | Molecular pathology of hepatic neoplasms: classification and clinical significance |
| Q24635267 | Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma |
| Q35289547 | Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study |
| Q50534138 | Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet. |
| Q37801938 | Neoplasms of the hepatobiliary system: clinical presentation, molecular pathways and diagnostics |
| Q37876335 | New acquisition techniques: fields of application |
| Q30448048 | New paradigm for management of hepatocellular carcinoma by imaging |
| Q50241691 | No Need of Immediate Treatment for Hypovascular Tumors Associated with Hepatocellular Carcinoma |
| Q27015959 | Nodule in Liver: Investigations, Differential Diagnosis and Follow-up |
| Q48792736 | Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging |
| Q55384238 | Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. |
| Q43035203 | Oncogenetic tree modeling of human hepatocarcinogenesis |
| Q38646886 | Ongoing challenges in the diagnosis of hepatocellular carcinoma |
| Q53148303 | Optimal injection rate and volume of contrast medium for observing hemodynamics of a hepatocellular carcinoma structure model. |
| Q53089913 | Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis. |
| Q90703325 | Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification |
| Q47430256 | Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior |
| Q57782479 | Pathologie hépatique Cirrhose et carcinome hépatocellulaire : indications et rôles de la biopsie hépatique |
| Q38505083 | Pathology-MRI Correlation of Hepatocarcinogenesis: Recent Update |
| Q84847825 | Pelioid-type well-differentiated hepatocellular carcinoma in a patient with a history of taking oral contraceptives: report of a case |
| Q34067908 | Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules |
| Q37649636 | Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas |
| Q49382799 | Polymorphic multiple hepatocellular adenoma including a non-steatotic HNF1α-inactivated variant |
| Q37491353 | Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy |
| Q39212821 | Potential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients |
| Q26784228 | Potentiality of immunotherapy against hepatocellular carcinoma |
| Q28079681 | Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update |
| Q38255718 | Preoperative gadoxetic Acid-enhanced MRI and simultaneous treatment of early hepatocellular carcinoma prolonged recurrence-free survival of progressed hepatocellular carcinoma patients after hepatic resection. |
| Q51075521 | Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. |
| Q28272678 | Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges |
| Q53059724 | Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis. |
| Q36257609 | Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis |
| Q49884601 | Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation |
| Q26772304 | Proteoglycans in liver cancer |
| Q48728280 | Quantification of liver perfusion using multidelay pseudocontinuous arterial spin labeling |
| Q33784125 | Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI. |
| Q37910079 | Radiofrequency ablation of high-grade dysplastic nodules |
| Q27027683 | Radiological diagnosis of hepatocellular carcinoma |
| Q64993911 | Radiomics and radiogenomics of primary liver cancers. |
| Q33651997 | Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma |
| Q52733595 | Rate of seeding with biopsies and ablations of hepatocellular carcinoma: A retrospective cohort study. |
| Q28075361 | Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI |
| Q86069324 | Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver |
| Q38366588 | Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma |
| Q37619600 | Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits. |
| Q35949672 | Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C. |
| Q37706763 | Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications |
| Q35832440 | Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma |
| Q38552269 | Small hepatocellular carcinoma: current and future approaches |
| Q37688115 | Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma |
| Q37857056 | Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. |
| Q26740317 | Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver Cirrhosis |
| Q36942569 | Surveillance programmes for early detection of hepatocellular carcinoma |
| Q28082702 | Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan |
| Q33944283 | TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis |
| Q53232555 | Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. |
| Q43108443 | The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy |
| Q47207387 | The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma |
| Q90729800 | The Effects of Thoracic Epidural Analgesia during Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma |
| Q91594116 | The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up? |
| Q47160125 | The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
| Q54091462 | The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population. |
| Q38635474 | The biology of Hepatocellular carcinoma: implications for genomic and immune therapies |
| Q92382505 | The clinical significance of lipopolysaccharide binding protein in hepatocellular carcinoma |
| Q92714304 | The clinicopathological characterization of small hepatocellular carcinoma with fibrous stroma |
| Q38936429 | The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline |
| Q40707183 | The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver. |
| Q37720697 | The importance of a multidisciplinary approach to hepatocellular carcinoma |
| Q26996805 | The role of interventional radiology in the management of hepatocellular carcinoma |
| Q47151061 | The stromal morphological changes for differential diagnosis of uninodular high-grade dysplastic nodule and well-differentiated small hepatocellular carcinoma |
| Q84230646 | The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging |
| Q42201891 | The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area |
| Q38371630 | Tissue diagnosis of hepatocellular carcinoma |
| Q39860927 | Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence |
| Q58021482 | Treatment of early hepatocellular carcinoma: Towards personalized therapy |
| Q38874225 | Tumor Hemodynamics and Hepatocarcinogenesis: Radio-Pathological Correlations and Outcomes of Carcinogenic Hepatocyte Nodules. |
| Q37798176 | Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology |
| Q35356022 | Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice |
| Q46444940 | Ultrasonography fusion imaging system increases the chance of radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on conventional ultrasonography |
| Q34983911 | Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma |
| Q37356150 | Update on new approaches in the management of hepatocellular carcinoma |
| Q53001457 | Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chroni |
| Q53674461 | Usefulness of early vascular phase images from contrast-enhanced ultrasonography using Sonazoid for the diagnosis of hypovascular hepatocellular carcinoma. |
| Q84581886 | Using loss of heterozygosity of microsatellites to distinguish high-grade dysplastic nodule from early minute hepatocellular carcinoma |
| Q52990998 | Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma. |
| Q49014010 | Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression |
| Q33688431 | Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs |
| Q91997710 | Vessel co-option in cancer |
| Q92805362 | Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma |
| Q40046596 | Viral hepatitis and liver cancer. |
| Q51367260 | Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration. |
| Q91696477 | [Guidelines for application of computer-assisted indocyanine green molecular fluorescence imaging in diagnosis and surgical navigation of liver tumors (2019)] |
| Q84889580 | [Highly differentiated liver tumors: recent developments and their diagnostic application] |
| Q87421151 | [National S3 guidelines on hepatocellular carcinoma] |
| Q53225138 | [Primary liver tumors : hepatocellular versus intrahepatic cholangiocellular carcinoma]. |
| Q92452034 | [Three-dimensional visualization combined with indocyanine green fluorescence imaging in diagnosis and treatment of primary hepatocellular carcinoma] |
Search more.